MedTrace Logo

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

NCT05069883 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-10-06

No results posted yet for this study

Summary

It was a randomized controlled trial conducted at department of Urology, Armed Forces Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the recurrence rate of urethral strictures.

Conditions

  • Recurrence

Interventions

DRUG

Steroid Drug

In this group Oral steroid medication after Direct Vision Internal Urethrotomy

DRUG

No steroid

In this group no Oral steroid medication (palcebo medication) after Direct Vision Internal Urethrotomy

Sponsors & Collaborators

  • Armed Forces Institute of Urology, Rawalpindi

    collaborator OTHER

  • Services Hospital, Lahore

    lead OTHER_GOV

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05069883 on ClinicalTrials.gov